Von Willebrand factor collagen-binding capacity predicts in-hospital mortality in COVID-19 patients: insight from VWF/ADAMTS13 ratio imbalance

Circulating Von Willebrand factor and high molecular weight multimers as markers of endothelial injury predict COVID-19 in-hospital mortality

(2021) Aurélien Philippe et al.   ANGIOGENESIS

Angiopoietin-2 as a marker of endothelial activation is a good predictor factor for intensive care unit admission of COVID-19 patients

(2020) David M. Smadja et al.   ANGIOGENESIS

ADAMTS13 activity, von Willebrand factor, factor VIII and D-dimers in COVID-19 inpatients

(2020) R. Escher et al.   THROMBOSIS RESEARCH

Pulmonary and cardiac pathology in African American patients with COVID-19: an autopsy series from New Orleans

(2020) Sharon E Fox et al.   Lancet Respiratory Medicine

Curative anticoagulation prevents endothelial lesion in COVID‐19 patients

(2020) Lina Khider et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Respiratory mechanics and gas exchanges in the early course of COVID-19 ARDS: a hypothesis-generating study

(2020) J.-L. Diehl et al.   Annals of Intensive Care

A relative ADAMTS13 deficiency supports the presence of a secondary microangiopathy in COVID 19

(2020) Nicola Martinelli et al.   THROMBOSIS RESEARCH

The ADAMTS13‐von Willebrand factor axis in COVID‐19 patients

(2020) Ilaria Mancini et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Consensus on the standardization of terminology in thrombotic thrombocytopenic purpura and related thrombotic microangiopathies

(2017) M. Scully et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

von Willebrand disease: advances in pathogenetic understanding, diagnosis, and therapy

(2013) D. Lillicrap   Hematology-American Society of Hematology Education Program